eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2011
vol. 15
 
Share:
Share:
abstract:
Original paper

Elevated levels of serum transforming growth factor-β 1 in oesophageal squamous cell carcinoma patients

Dorota Diakowska
,
Andrzej Lewandowski
,
Krystyna Markocka-Mączka
,
Krzysztof Grabowski

Współcz Onkol 2011; 15 (3): 137–141
Online publish date: 2011/07/04
View full text Get citation
 
PlumX metrics:
Background : Transforming growth factor- β 1 (TGF- β 1) is a multifunctional cytokine involved in cancer development. The diagnostic significance of serum levels of transforming growth factor- β 1 (sTGF- β 1) in the oesophageal squamous cell carcinoma (ESCC) remains unclear. The aim of the study was to analyze sTGF- β 1 concentrations in ESCC patients. The sTGF- β 1 levels were assessed according to the clinical parameters in cancer patients. We determined sTGF- β 1 concentrations in ESCC patients before and after oesophagectomy. The correlation between sTGF- β 1 and serum levels of vascular endothelial growth factor (sVEGF-A) was examined as well.

Material and methods: The study included 115 patients with ESCC and 57 healthy controls. Concentrations of sTGF- β 1 were measured by ELISA tests and were compared with clinical parameters of cancer patients. Serum samples for sTGF- β 1 evaluation 3 months after surgical resection were available in 41 cases.

Results : Serum TGF- β 1 level was significantly higher in ESCC compared to the control group (p < 0.001). Serum levels of TGF- β 1 positively correlated with the depth of tumour invasion (p = 0.042). There were no differences in sTGF- β 1 levels in patients stratified by the presence of regional and distant metastases and stage of cancer progression. The level of sTGF- β 1 was significantly lower in ESCC patients after oesophagectomy than before surgical treatment (p = 0.002). A positive correlation between sTGF- β 1 and sVEGF-A (p = 0.017) was observed.
keywords:

oesophageal squamous cell carcinoma, transforming growth factor- β 1, tumourgenesis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.